A single dose of the LSD-based therapy DT120 produced rapid antidepressant effects that remained significant through 12 weeks in a pivotal phase 3 trial of major depressive disorder.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/positive-topline-results-novel-lsd-formulation-major-2026a1000lt5?src=rss
Author :
Publish date : 2026-06-26 11:53:00
Copyright for syndicated content belongs to the linked Source.
